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dDepartment of Medical Imaging, Royal University Hospital, Saskatoon, Saskatchewan, CanadaAbstractPurpose: Follow-up study to observe if provincial mean effective radiation dose for head, chest, and abdomen-pelvis (AP) computed
tomographies (CTs) remained stable or changed since the initial 2006 survey.
Methods: Data were collected in July 2008 from Saskatchewan’s 13 diagnostic CT scanners of 3358 CT examinations. These data included
the number of scan phases and projected dose length product (DLP). Technologists compared projected DLP with 2006 reference data before
scanning. Projected DLP was converted to effective dose (ED) for each head, chest, and AP CT. The total dose that the patients received with
scans of multiple body parts at the same visit also was determined.
Results: The mean ( SD) provincial ED was 3.4  1.6 mSv for 1023 head scans (2.7  1.6 mSv in 2006), 9.6  4.8 mSv for 588 chest
scans (11.3  8.9 mSv in 2006), and 16.1  9.9 mSv for 983 AP scans (15.5  10.0 mSv in 2006). Single-phase multidetector row CT ED
decreased by 31% for chest scans (9.5  3.9 mSv vs 13.7  9.7 mSv in 2006) and 17% for AP scans (13.9  6.0 mSv vs 16.8  10.6 mSv in
2006) and increased by 19% for head scans (3.2  1.2 mSv vs 2.7  1.5 mSv in 2006). The total patient dose was highest (33.8  10.1 mSv)
for the 20 patients who received head, neck, chest, and AP scans during a single visit. Because of increased utilisation and the increased CT
head dose, Saskatchewan per capital radiation dose from CT increased by 21% between 2006 and 2008 (1.14 vs 1.38 mSv/person per year).
Conclusion: Significant dose and variation reduction was seen for single-phase CT chest and AP examinations between 2006 and 2008,
whereas CT head dose increased over the same interval. These changes, combined with increased utilisation, resulted in per capita increase in
radiation dose from CT between the 2 studies.ResumeObjectif : Etude de suivi visant a observer si la moyenne provinciale des doses efficaces de radiation a la tomodensitometrie cerebrale,
thoracique et abdominopelvienne etaient restees stables ou avaient change depuis l’etude originale de 2006.
Methodes : Les donnees ont ete recueillies en juillet 2008 a partir des 13 tomodensitometres diagnostiques de la Saskatchewan, au cours de 3
358 examens tomodensitometriques. Ces donnees comprenaient le nombre de passes et le produit dose-longueur (PDL) estime. Les tech-
nologues ont compare le PDL estime aux donnees de reference de 2006 avant les examens. Le PDL estime a ete converti en dose efficace
pour chaque examen tomodensitometrique cerebral, thoracique et abdominopelvien. La dose totale rec¸ue par les patients ayant subi des
examens de multiples parties du corps lors d’une me^me visite a egalement ete determinee.
Resultats : La dose efficace moyenne ( SD) etait de 3,4  1,6 mSv pour 1 023 tomodensitometries cerebrales (2,7  1,6 mSv en 2006), 9,6
 4,8 mSv pour 588 tomodensitometries thoraciques (11,3  8,9 mSv en 2006) et 16,1  9,9 mSv pour 983 tomodensitometries abdom-
inopelviennes (15,5  10,0 mSv en 2006). La dose efficace en tomodensitometrie monopasse a detecteurs multiples a diminue de 31 % pour
la tomodensitometrie thoracique (9,5  3,9 mSv contre 13,7  9,7 mSv en 2006) et de 17 % pour la tomodensitometrie abdominopelvienne
(13,9  6,0 mSv contre 16,8  10,6 mSv en 2006); elle a toutefois augmente de 19 % pour la tomodensitometrie cerebrale (3,2  1,2 mSv
contre 2,7  1,5 mSv en 2006). La dose totale par patient etait la plus forte (33,8  10,1 mSv) pour les 20 patients ayant rec¸u des examens* Address for correspondence: David A. Leswick, MD, FRCPC, Department of Medical Imaging, Royal University Hospital, 103 Hospital Dr, Saskatoon,
Saskatchewan S7N 0W8, Canada.
E-mail address: david.leswick@saskatoonhealthregion.ca (D. A. Leswick).
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184 C. S. Dumaine et al. / Canadian Association of Radiologists Journal 63 (2012) 183e191tomodensitometriques cerebral, cervical, thoracique et abdominopelvien au cours de la me^me visite. En raison d’une utilisation accrue et de
l’augmentation de la dose en tomodensitometrie cerebrale, la dose de radiation due a la tomodensitometrie par habitant a augmente de 21 %
entre 2006 et 2008 (1,14 contre 1,38 mSv par personne par annee).
Conclusion : Une reduction significative de la dose et de la variation a ete observee entre 2006 et 2008 pour les examens thoraciques et
abdominopelviens en tomodensitometrie monopasse a detecteurs multiples, tandis que la dose de rayonnement due aux examens tomo-
densitometriques cerebraux a augmente au cours du me^me intervalle. Ces changements, conjugues a une utilisation accrue, ont entra^ıne une
augmentation de la dose de rayonnement due a la tomodensitometrie par habitant entre les deux etudes.
 2012 Canadian Association of Radiologists. All rights reserved.
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computed tomographies (CTs) is often underestimated by
both physicians and patients [1]. However, at a time when
CTs in Canada represent approximately 12% of medical
imaging procedures and account for 60%-70% of medically
produced radiation, such an underestimation can have severe
consequences [2e4]. It now is estimated that 1.5%-2% of
cancers in the United States may be attributable to radiation
from diagnostic CT [5].
Over the past few decades, as new indications for CT use
have evolved and newer CT technology has developed, there
has been an increase in both the number of CTs performed
and the radiation dose per CT [2]. Recent studies show that,
in the United States, the dose from CT contributes between
26% and 50% of total population radiation exposure, with
most of the remainder attributed to background radiation and
other medical radiation [6]. In 2006, the BEIR VII report on
health risks from exposure to low levels of ionizing radiation
was published, which shows that the relationship between
low-dose ionizing radiation and the incidence of solid cancers
and leukaemia, respectively, are the linear no-threshold and
linear quadratic models [7]. The doses described in the BEIR
VII report are in the range of diagnostic CTs.
Saskatchewan’s population is approximately one million
residents. Saskatchewan’s 2 major cities, Saskatoon and
Regina, each have populations of approximately 200,000.
There are 13 diagnostic CT scanners in Saskatchewan, 7 of
which are located in the cities of Saskatoon and Regina, and
6 of which are located in smaller rural health care facilities.
In 2006, there were 122,035 CTs performed in Saskatch-
ewan; in 2008, this increased by 17.6% to 143,449 scans
(P. Au, Saskatchewan Ministry of Health, written personal
communication, November 10, 2010). A Saskatchewan CT
radiation dose survey in 2006 revealed the provincial mean
( SD) effective doses for head, chest, and abdomen-pelvis
(AP) CTs were 2.7  1.6 mSv, 11.3  8.9 mSv, and 15.5
 10.0 mSv, respectively [8]. The 2006 survey involved 12
of the province’s 13 CT scanners. These doses were similar
to other published studies, especially a 2006 publication
from British Columbia [8,9]. However, there was observable
variation of effective doses among the 12 CT scanners
involved in the study, with some displaying doses much
higher than the provincial mean [8].
This 2008 follow-up survey assessed whether or not these
provincial doses had remained stable or were decreased andbetter standardized across the province. A combination of
factors may have altered dose levels in the 2 years between
studies, including feedback on 2006 dose levels at each site,
increased awareness of dose-related issues, a self-check
reference card, and increased technologist experience.Patients and Methods
Ethics approval was obtained from the University of
Saskatchewan Research Ethics Board. The Saskatchewan
hospitals that participated in the survey were Battlefords
Union Hospital (North Battleford), Lloydminster Hospital
(Lloydminster), Moose Jaw Union Hospital (Moose Jaw),
Pasqua Hospital (Regina), Regina General Hospital (Regina)
(with 2 scanners), Royal University Hospital (Saskatoon)
(with 2 scanners), Saint Paul’s Hospital (Saskatoon),
Saskatoon City Hospital (Saskatoon), Swift Current Regional
Hospital (Swift Current), Victoria Hospital (Prince Albert),
and Yorkton Regional Health Centre (Yorkton). This group
of CT scanners represented a variety of CT scanner brands
and detector-row (DR) numbers, which ranged from single
DR scanners (SDR) to a 64 DR scanner, including 1 HiSpeed
CTi (SDR) (GE Healthcare, Milwaukee, WI), 1 Somatom þ4
(SDR) (Siemens, Erlangen, Germany), 2 Light Speed Ultra
(8 DR) (GE Healthcare), 3 Brilliance 10 (10 DR) (Philips,
Andover, MA), 1 Light Speed 16 (16 DR) (GE Healthcare), 2
Brilliance 16 (16 DR) (Philips), 1 Brilliance 40 (40 DR)
(Philips), and 1 VCT (64 DR) (GE Healthcare). At the time,
this represented all diagnostic CT scanners in the province.
There were no new scanner installs or equipment upgrades
between the 2006 and 2008 dose surveys.
At the beginning of the survey, packages that contained all
required materials were distributed to each site. These
packages included data collection sheets and instructions,
a summary of the 2006 results, a copy of ‘‘Computed
tomography: an increasing source of radiation exposure’’ by
Brenner and Hall [5], and a site-specific reference card. This
reference card displayed the provincial and site-specific
mean dose-length product (DLP) from 2006 for each scan
type, as well as the value that was 25% higher than the site’s
mean 2006 DLP. The intention of these reference cards was
to allow CT technologists to conduct a prescan comparison
between the estimated DLP of the scan that they were about
to perform and their mean DLP from 2006.
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CT technologists at each location. The data collected
included patient age and initials, the department from which
the patient was referred (emergency, inpatient, or outpatient),
body part scanned, scan type (routine, vascular, cardiac, or
musculoskeletal), whether the scan used a fixed tube current
or an automatic tube current modulation system, the number
of phases for the scan, the projected DLP for each phase, and
the total projected DLP. Projected DLP was provided on the
console of 12 of the 13 CT scanners involved in the study.
Because the Somatom scanner (Siemens) does not display
DLP values on the console, CT technologists manually
calculated the DLP by using the CT dose index and the scan
length to generate data from this scanner. The product of the
CT dose index (measured in mGy) and the scan length (cm)
yields the DLP (measured in mGy$cm).
Technologists were asked to record data as the scan was
planned. By using the reference cards, the technologists were
asked to compare the projected DLP for each scan to their
site’s 2006 DLP and record whether the DLP was lower,
similar to, or greater than 25% higher. If the recorded DLP
was more than 25% higher, then they were asked to ratio-
nalize this high dose. A list of reasons for which CTs are
known to have high radiation dose was supplied and included
the following: tall patient, overweight patient, multiphase
scan, cardiac scan, and vascular scan. Technologists also
could fill in their own answer if this list did not encompass
their reason for using a high radiation dose.
Data collection packages were returned to a single author
(C.D.), and the data that were recorded were entered into
Excel 2003 spreadsheets (Microsoft, Redmond, WA). These
data were converted to SAS statistical software version 9.1
(SAS Institute Inc, Cary, NC). All statistical analyses were
carried out with the SAS software.
From the 13 CT scanners involved in the survey, a total of
3358 scans were collected; 140 CTs were removed due to
incomplete data, and 251 CTs were excluded from data
analysis because they were of tissue types not analysed in
this survey. Therefore, a total of 2722 scans (1023 head, 588
chest, 983 AP, 99 abdomen, and 31 pelvis) were used for
effective dose comparison with 2006. An additional 243 CTs
(including 12 facial bones, 95 neck, 92 cervical spine, and 44
sinus CTs) were assessed for determining total radiation dose
in patients receiving CTs of more than 1 body part at a single
visit. The average age of the patients in this study was 57.7
years old, with a range from newborn to 98 years.
To calculate the effective radiation dose, the projected
DLP of each scan was multiplied by a conversion factor for
each body part. The conversion factors used were the
following: 0.0023 mSv/mGy$cm for head (including CT
angiogram [CTA] Circle of Willis [COW] studies and sinus
CT scans), 0.015 mSv/mGy$cm for abdomen CTs, 0.019
mSv/mGy$cm for pelvis CTs, 0.017 mSv/mGy$cm for chest
and combined AP CTs, and 0.0054 for cervical spine), neck,
CTA carotids, and facial bone CTs [8e10]. Even though the
head, chest, abdomen, pelvis, and AP conversions factors
differed slightly from Huda’s updated values [10], they werekept as previously used to allow comparison with the 2006
Saskatchewan study [8].
Provincial mean (SD) effective radiation doses were
calculated for head, chest, abdomen, pelvis, and combined
AP scans. Mean (SD) effective dose for CT head, chest, and
AP were calculated for each individual scanner, as well as for
single- vs multiphase examinations for both the single
detector row and multidetector row CT scanners. Due to
a limited sample of isolated abdomen and pelvis CT scans in
both the 2008 and 2006 data collections, site-specific doses
were not calculated for these examination types.
Total effective radiation dose received by patients
undergoing CTs of 2 or more different body parts during
a single visit was calculated. For each combination of body
parts, the mean (SD) and range were calculated. The body
parts assessed in this analysis were the head (including facial
bones, sinuses, and CTA COW), neck, chest, and AP.
All values were compared with the 2006 values by using
descriptive statistics to summarize the data. Initial descrip-
tive statistics were used to determine whether to use para-
metric or nonparametric statistics [11]. A Wilcoxon signed
rank test was used for comparison of continuous variables
between 2006 and 2008, and categorical variables were
compared by using a c2 test. A P value of less than .05 was
considered statistically significant for this study. Upon
completion of data analysis, radiation dose data were
disseminated back to the participating sites, which were
made aware of their own dose data while being blinded to the
identities of the other hospitals.
Any details that linked specific detector row numbers and
site names to radiation dose levels were omitted from this
article. Given the relatively small number of CT scanners in
Saskatchewan, divulging this information makes it virtually
impossible to uphold the promise of site anonymity, which
was a key factor in recruitment.Results
The mean (SD) effective doses for head, chest, and AP
scans were found to be 3.4  1.6 mSv (range, 0.4-11.3 mSv),
9.6  4.8 mSv (range, 0.2-42.9 mSv), and 16.1  9.9 mSv
(range, 1.9- 89.0 mSv), respectively. The overall 2008
provincial mean effective radiation dose for all scan types is
summarized in Table 1, and these data are compared with
estimated effective radiation doses as found in other studies,
including the 2006 Saskatchewan study [8,9,12e15].
The histograms displayed in Figure 1 demonstrate the
variation in effective dose for head, chest, and AP scans. The
majority of scans clustered near the mean values, with only
23 head scans, 8 chest scans, and 21 AP scans more than 3
SDs from the mean dose.
The provincial and site-specific mean (SD) doses for both
overall and single phase scans of the head (Figure 2), chest
(Figure 3), and AP (Figure 4) are presented. These figures
display the intersite variation in dose; for single phase studies,
site-specific mean effective doses varied among sites by
Table 1
Summary of Saskatchewan mean effective doses (mSv) vs referenced studies and guidelines
Saskatchewan,
2008
Saskatchewan,
2006 [8]
British
Columbia, 2006 [9]
United Kingdom,
2004 [12]
Germany,
2003 [13]
European Union,
1999 [14]
European
guidelines, 2000 [15]
Head 3.4 2.7 (e21%) 2.8 (e18%) 1.5 (e56%) 2.8 (e18%) 2 (e41%) 2.4 (e29%)
Chest 9.6 11.3 (þ18%) 9 (e6%) 5.8 (e40%) 5.7 (e41%) 8.8 (e8%) 11.1 (þ16%)
Abdomen and
pelvis
16.1 15.5 (e4%) 16.5 (þ2%) 7.1 (e56%) 14.4 (e11%)
Abdomen 12.4 11.7 (e6%) 10.2 (e18%) 5.3 (e57%) 9 (e27%) 11.7 (e6%)
Pelvis 11.5 8.6 (e25%) 9.1 (e21%) 7.2 (e37%) 6.6 (e43%) 10.8 (e6%)
Average doses from this study are shown in the Saskatchewan 2008 column.
All mean effective doses are presented in mSv with percentage difference from Saskatchewan 2008 data in parentheses.
Although the Saskatchewan data columns are described as 2008 and 2006, respectively, to represent the data collection periods, all other dates are the dates of
final publication. Blank values represent data not provided in the referenced study.
Figure 1. Provincial-wide effective dose histograms for the head (A), chest
(B), and abdomen-pelvis (C) scans. Note that although the range of effective
doses is very wide, this is attributable to a small number of outliers at the
high end of the range for each scan type. Dose histograms from 2006 are
inlaid for comparison. Note that dose ranges are the same for 2006 and 2008
histograms with histogram ranges from 0-13 mSv for head examinationss
(A), 0-52 mSv for chest examinations (B), and 0-89 mSv for abdomen-pelvis
examinations (C). CT ¼ computed tomography.
Figure 2. These figures summarize the radiation dose from head computed
tomographies (CTs) in Saskatchewan. (A) summarizes radiation dose for all
head CT scans and (B) summarizes radiation dose from single-phase head
CTs. The x-axis indicates the scanners, which are unnamed to retain
anonymity. Scanners 1 and 2 are single-detector row scanners, with scanners
3-12 representing the multidetector row scanners, with no relationship
between scanner number and CT scanner design. The numbers in paren-
theses indicate the number of scans in 2006 and the number of scans in 2008.
Single-phase data are not presented for scanner 12 for 2006, because these
data were not provided by that site. No data are presented for scanner 13 for
2006, because this location did not participate in the 2006 study. Note the
difference in the y-axis scale between Figure 2 and Figures 3 and 4.
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Figure 3. These figures summarize the radiation dose from chest computed
tomographies (CTs) in Saskatchewan. (A) Summarizes radiation dose for all
chest CTs, and (B) summarizes radiation dose from single-phase chest CTs.
The x-axis indicates the scanners, which are unnamed to retain anonymity.
Scanners 1 and 2 are single-detector row scanners, with scanners 3-12
representing the multidetector row scanners, with no relationship between
scanner number and CT scanner design. The numbers in parentheses indicate
the number of scans in 2006 and the number of scans in 2008, respectively.
Single-phase data are not presented for scanner 12 for 2006, because these
data were not provided by that site. No data are presented for scanner 13 for
2006, because this location did not participate in the 2006 study. Note the
difference in the y-axis scale between Figure 2 and Figures 3 and 4.
Figure 4. These figures summarize the radiation dose from abdomen-pelvis
(AP) computed tomographies (CT) in Saskatchewan. (A) Summarizes
radiation dose for all AP CTs, and (B) summarizes radiation dose from
single-phase AP CTs. The x-axis indicates the scanners, which are unnamed
to retain anonymity. Scanners 1 and 2 are single-detector row scanners with
scanners 3-12 representing the multidetector row scanners, with no rela-
tionship between scanner number and CT scanner design. The numbers in
parentheses indicate the number of scans in 2006 and the number of scans in
2008, respectively. Single-phase data are not presented for scanner 12 for
2006, because these data were not provided by that site. No data are pre-
sented for scanner 13 for 2006, because this location did not participate in
the 2006 study. Note the difference in the y-axis scale between Figure 2 and
Figures 3 and 4.
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tions, respectively, vs factors of 2.8, 6.9, and 3.6 in 2006 [8].
Variation in dose within each site can be visualized as the SD
bars in Figures 2-4. The SD bars within many sites are smaller
in 2008, which indicate less variation in dose at these sites.
The 2008 and 2006 mean provincial effective radiation
dose values for head, chest, and AP scans (all scans, single-
phase, and multiphase scans) are compared in Table 2 [8].
Although the overall mean values include all scans recorded,
some scans were excluded from the single- and multiphase
values because of either incomplete or confusing data entry
regarding number of phases. The dose from head CT
has increased significantly in all categories since 2006(P < .0001). Chest scans showed a 17% decrease (P ¼ .0112)
for single-phase scans, but no significant change for multi-
phase scans or overall dose. AP scans show a 9% reduction
in dose for single-phase scans (P ¼ .0491), as well as a 63%
increase in dose for multiphase scans (P < .0001) and a 4%
increase in overall dose (P ¼ .011).
A similar comparison for only the multidetector row
scanners is presented in Table 3. Also, some scans were
excluded from single- and multiphase assessment because of
either incomplete or confusing data entry. Head CTs show
a 19% dose increase for single-phase scans (P < .0001),
a 36% increase for multiphase scans (P < .0001), and a 29%
increase for all scans (P < .0001). Chest CTs show a 31%
Table 2
Mean effective dose and percentage differences from 2006 for all scans, single-phase scans, and multiphase scans on all 13 computed tomographies
Overall scansa Single-phase scansa Multiphase scansa
2008 2006 [8] Change (P value) 2008 2006 [8] Change (P value) 2008 2006 [8] Change (P value)
Head 3.4 (1023)  1.6 2.7 (640)  1.6 þ26% (<.0001) 3.0 (746)  1.3 2.5 (484)  1.4 þ20% (<.0001) 4.2 (277)  2.1 3.0 (114)  2.0 þ40% (<.0001)
Chest 9.6 (588)  4.8 11.3 (376)  8.9 e15% (.667) 9.0 (522)  4.0 10.8 (286)  9.3 e17% (.0112) 13.6 (66)  7.7 13.1 (54)  8.0 þ4% (.541)
Abdomen-pelvis 16.1 (983)  9.9 15.5 (578)  10.0 þ4% (0.011) 13.6 (795)  6.1 15.0 (400)  10.1 e9% (.0491) 26.6 (188)  14.7 16.3 (135)  10.2 þ63% (<.0001)
Overall mean scans includes all scans recorded, whereas some scans were excluded from the single- and multiphase scans because of either incomplete or confusing data entry regarding number of phases.
The change is percentage difference from 2006, with P value in parentheses based on Wilcoxon sign rank testing.
aThe data are presented in the format: mean dose (sample size)  SD.
Table 3
Mean effective dose and percent differences from 2006 for all scans, single-phase and multiphase scans on the 11 multidetector row CT scanners in the survey (excluding the 2 single detector row scanners)
Overall scansa Single-phase scansa Multiphase scansa
2008 2006 [8] Change (P value) 2008 2006 [8] Change (P value) 2008 2006 [8] Change (P value)
Head 3.6 (897)  1.6 2.8 (534)  1.6 þ29% (<.0001) 3.2 (663)  1.2 2.7 (406)  1.5 þ19% (<.0001) 4.5 (234)  2.1 3.3 (88)  2.1 þ36% (<.0001)
Chest 10.0 (537)  4.7 13.6 (284)  9.0 e26% (<.0001) 9.5 (479)  3.9 13.7 (200)  9.7 e31% (<.0001) 14.7 (58)  7.6 14.2 (48)  7.8 þ4% (.639)
Abdomen-pelvis 16.7 (913)  9.9 17.0 (484)  10.3 e2% (0.967) 13.9 (752)  6.0 16.8 (319)  10.6 e17% (0.004) 29.5 (161)  13.8 17.2 (122)  10.3 þ72% (<.0001)
Overall scans includes all scans recorded while some scans were excluded from the single- and multiphase values because of either incomplete or confusing data entry regarding the number of phases.
It should be noted that the mean (SD) provincial dose for the 2 single detector row scanners was 2.0  0.6 mSv for the head, 4.4  1.1 mSv for the chest, and 8.1  3.0 mSv for the abdomen-pelvis scans.
The P value in parentheses is based on Wilcoxon sign rank testing.
aThe data are presented in the format: mean dose (sample size)  SD.
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significant change for multiphase scans, and a 26% decrease
for all scans (P < .0001). AP CTs show a 17% dose reduction
in single-phase scans (P ¼ .004) and a 72% dose increase in
multiphase scans (P < .0001), but no significant change
when all scans are taken into account.
A weighted average dose per CT scan was calculated at
9.37 mSv in 2006 and 9.62 mSv in 2008. Based on
a provincial population of 1,000,000 and the number of
annual CTs (122,035 in 2008 and 143,449 in 2008), the
radiation dose per capita from CT in Saskatchewan increased
by 21% from 1.14 mSv/person per year in 2006 to 1.38 mSv/
person per year in 2008.
The data that were collected on patients who received CTs
of more than 1 body part on their visit are summarized in
Table 4. A total of 295 patients received more than 1 scan
type during their CT visit. The highest combination doses
were for patients who received head, neck, chest, and
abdomen-pelvis CTs, who were exposed to a mean (SD) dose
of 33.8  10.1 mSv (range, 24.3-61.8 mSv).
There was no significant difference in examination dose
related to the centre from where patients had been referred.
Specifically, head CT mean doses were 3.6 mSv, 3.2 mSv,
and 3.2 mSv for emergency, inpatient, and outpatient,
respectively, with chest mean doses of 10.6 mSv, 9.1 mSv,
and 9.5 mSv, respectively, and AP mean doses of 15.2 mSv,
16.4 mSv, and 16.3 mSv, respectively.
Excluding 2006 data from site 12 (which did not provide
information regarding the number of phases in that survey),
there was a change in percentage of single- vs multiphase
scans between the 2 surveys. Of head scans, 80% (482/602)
were single phase in 2006, which decreased to 73% (744/
1023) in 2008; 77% (281/365) of chest scans were single
phase in 2006, which increased to 89% (522/588) in 2008;
72% of AP scans (390/540) were single phase in 2006, which
increased to 81% (792/983) in 2008. Multiphase examina-
tions ranged from 1-6 phases for chest and 1-4 phases for AP.Table 4
Data collected from patients who received computed tomographic scans or
more than one body part on a single visit
Multiple
no. Type No.
Mean (SD)
dose (mSv) Range (mSv)
2 H and F-N 58 6.6  1.9 3.0e12.8
2 H and C 9 14.3  6.2 8.2e28.3
2 H and AP 14 20.7  8.8 11.6e46.5
2 F-N and C 13 12.2  4.3 6.2e22.5
2 F-N and AP 3 18.1  4.2 14.7e22.8
2 C and A-P 136 22.1  9.6 2.9e59.7
3 H, F-N, and C 3 17.1  5.7 10.7e21.5
3 H, F-N, and AP 6 22.7  3.6 16.0e26.3
3 F-N, C, and AP 18 26.2  12.8 7.8e55.6
3 H, C, and AP 15 24.0  8.3 13.4e45.1
4 H, F-N, C, and AP 20 33.8  10.1 24.3e61.8
The columns, from left to right, represent: the number of body parts scanned,
the body parts scanned, the number of patients who received this scan
combination, the mean effective total dose from each scan combination, and
the range of the effective doses from each scan combination.
AP ¼ abdomen-pelvis; C ¼ chest; F-N ¼ facial bones or neck; H ¼ head.Discussion
Past studies compared CT radiation dose to both the
radiation received by Japanese survivors of atomic bombs
and workers within the nuclear industry [5]. A long-term
study of approximately 25,000 atomic bomb survivors indi-
cated that people who received radiation doses that ranged
from 5-150 mSv had a significant increase in the overall risk
of cancer [5]. The mean radiation dose received by individ-
uals in this group was 40 mSv [5]. A separate study of more
than 400,000 nuclear industry workers revealed an increased
risk of cancer mortality associated with exposure to an
average dose of 19.3 mSv [16].
In the past decade, many surveys have been performed to
quantify the effective radiation dose from CT; some of these
surveys, including the 2006 Saskatchewan survey, are
summarized in Table 1 [8,9,12e15]. In the 2 years since the
previous Saskatchewan dose study, several events have
occurred. First, to increase radiologist and technologist
awareness of dose levels at their site, results of the 2006
study were disseminated to the participating sites. Each site
had 2 years of increased experience, and the issue of CT dose
had become increasingly discussed in both the medical
literature and general media. As part of the 2008 survey,
a self-check reference card was provided to sites to be placed
at the CT console and referenced before each scan, which
allows technologists to compare the projected dose with the
2006 provincial mean and to their site’s 2006 mean. These
reference cards were created based on evidence that diag-
nostic reference levels help to improve quality control and
contribute to dose reduction efforts [17].
A focus on only the multidetector row scanners (MDCT)
is appropriate as the 2 Saskatchewan single detector row
scanners have both been replaced since completion of the
2008 data collection. Focusing on MDCTs allows for a more
accurate portrayal of Saskatchewan CT dose in the near
future, which also will allow comparison across Canada
because, as of January 2007, 89% of Canadian CT scanners
were MDCTs [2]. MDCTs are known to be associated with
higher dose, and focusing on them decreases the variability
in scanner design, which helps differences between the
studies become more apparent [8,9,13]. As Table 3 shows,
dose reduction in single-phase chest and AP scans was more
substantial when only MDCTs were assessed.
The major dose reductions observed were in single-
phase chest and AP scans. At some centres (specifically
site no. 8), the reduction was substantial. Changes were
most evident when isolating for single-phase scans because
they have less intrinsic variation, whereas multiphase scans
in the survey ranged from 2-6 phases, which created
a much wider range for the used dose and is statistically
supported by the narrower SD for MDCT single-phase than
multiphase studies in this 2008 survey (SD, 1.2 vs 2.1 mSv
for CT head; SD, 3.9 vs 7.6 mSv for chest; and SD, 6.0 vs
13.8 mSv for AP).
Variability in CT dose surveys is slightly complicated.
Variability in dose within an institution is to be expected if
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something particularly important when scanning pediatric
patients. Some variability in dose also should be expected
among institutions, which accounts for different scanner
technology and unique patient populations that an institution
sees. However, more significant variation and dose levels
above reference levels may indicate problems with either
equipment or scan protocols [18].
In this survey, there were improvements in the intersite
variation seen in 2006, with most sites having a mean dose
close to the provincial mean and smaller error bars than in
2006. This is best visualized in Figures 2-4. Lessening this
intersite variation helps to alleviate the worry that patient
dose from CT is dependent upon which centre they had the
scan.
Unfortunately, there were increases in head CT dose in
every subset analysis performed. Inquiry with the sites
revealed that, in 3 locations, there had been a change in head
CT protocol initiated in the 2 years between surveys. The
changes were by request of the radiologists at these sites,
who desired higher-quality images. A large proportion of the
total number of head CT studies was performed at these 3
locations, which may have skewed the provincial mean.
This increase in CT head doses also helped drive the
increase in the weighted average dose per CT from 9.37
mSv/scan in 2006 to 9.62 mSv/scan in 2008, which increased
weighted average dose per scan combined with the 17.6%
increase in total number of provincial CTs resulted in a 21%
increase in the radiation dose per capita in Saskatchewan
from 2006 to 2008. When assuming an average background
radiation exposure of 3 mSv, 6 mSv average dose from a CT,
60 million annual CTs, and an American population of 300
million, Coursey and Frush [6] calculated that 40% of the
American population’s CT dose was from CT in 2005. Their
calculation may be an overestimate, because it did not
include a dose from the CT in the denominator, whereas it
also may be underestimated because of the relatively low
average scan dose used [6]. Similar calculations that used
weighted average CT doses from Saskatchewan, background
exposure of 3 mSv (plus inclusion of weighted average CT
dose in the denominator) indicate that approximately 28%
and 31% of the province’s population radiation dose was
from CT in 2006 and 2008, respectively.
In the interval between 2006 and 2008, there also was
a change in the percentage of scans, which were single- vs
multiphase examinations. The percentage of chest and AP
scans that are single-phase increased from 77% to 89% and
72% to 81%, respectively. This change in itself is beneficial
in dose management as a prime strategy for reducing dose is
to limit the number of phases acquired [5,6]. The percentage
of head scans that were multiphases did increase, from 20%
to 27%, between the studies. One possible explanation for
this is that we were more explicit to include CTA examina-
tions of the COWas a phase in a CT head study, whereas this
was not explicitly stated in the 2006 survey. Anecdotally,
many referring physicians are more comfortable with CTA
studies of the head and neck, likely increasing the number ofthese orders in the 2 years between the studies. A New
England Journal of Medicine article by Brenner and Hall [5]
stated that a common CT study involves 2 or 3 scans with
dose ranges of 30 to 90 mSv. This is certainly not the case in
Saskatchewan.
Although there have been many previous studies on
average dose from individual examinations, there has been
a paucity of data in the literature on the total dose to patients
who received multiple scans at the same visit. Limited data
published from New Mexico in 2000 by Mettler et al [4]
indicated that 24% of patients who received head CTs also
had other body parts scanned, whereas 35% of patients who
received chest scans also received AP scans. In addition,
Mettler et al [4] indicated that, of patients who received AP
scans, 96% received more than 1 scan sequence that day. It is
unclear if this refers to the number of phases, number of
body parts, or a combination of these factors.
Multibody site scans can be thought of as similar to dose
estimates from full-body screening CT. A previous study
estimated the cancer risk associated with full-body CT
scanning [19]. By using a conservative screening scan
protocol, the dose from a scan of the third cervical vertebrae
to the symphysis pubis was estimated at 11.2 mSv [19]. The
risk of fatal malignancy varied with age, from 0.13% at age
25 years to 0.03% at age 75 years old [19]. This dose is lower
than our clinical ‘‘full-body’’ CT patients who received 33.8
 10.1 mSv during scans of the head, neck, chest, and AP. It
should be remembered that, because these doses are in the
range of doses experienced by atomic bomb survivors, it is
not an extrapolation of that data to lower levels [19].
In addition to the risk from individual scans, concern has
been growing for patients who receive multiple scans over
their imaging histories [20,21]. Sodickson et al [20] found
that, of patients who receive a CT, in the past 20 years, 33%
received more than 5 scans, 5% received more than 22 scans,
and 1% received more than 38 scans. By using estimated
doses of 2 mSv, 8 mSv, and 15 mSv for head, chest, and AP
scans, respectively, which corresponded to 15% of patients
who received more than 100 mSv, whereas 4% of patients
received more than 250 mSv [20]. Even though our dose
survey did not focus on patients who received repeated CTs,
minimizing dose for all patients will help decrease the dose
to the percentage of patients who receive multiple scans in
their lifetime.
As with any dose survey, this remains a study of current
practice and not optimal practice [8,9]. Given the geographi-
cally diverse nature of our survey, we limited the amount of
data collected to maximize participation. Although we ideally
would have collected both pre- and postscanning DLP, we had
to settle for prescanning DLP as a measure of increasing
compliance, with use of the reference card and data collection.
Use of the prescan estimated DLP was a limitation for 2
separate reasons. During data collection, it was noted that
estimated DLP was consistently higher than postexamination
DLP on the Brilliance 10 DR scanner (Philips) at 1 site by
19.5% for chest and 17.5% for AP scans, with no difference for
head examinations. Three Brilliance 10DR scanners (Phillips)
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by extensively investigating this when our data analysis was
nearing completion, these scanners had been either replaced or
had upgraded software since the data collection finished,
which precludes systematic investigation of this difference.
Because the prescan DLP was an overestimate of postscan
DLP on this scanner, if anything, this would have under-
estimated the dose reductions achieved. In addition, prescan
estimated DLP would not have accounted for additional
images required by technologists because of factors such as
patient movement or inadequate scan coverage on the initial
scan.
Another major limitation is that there was no evaluation of
changes in image quality as a result of dose reduction.
Although such analysis would have been a useful marker of
clinical utility of dose reduction, such a large task was
beyond the scope of this study.
Other limitations to this study include the fact that
complete comparison between all sites was not possible,
because 1 site in this study had not participated in the 2006
study and a separate site did not provide information on the
number of phases in 2006. Another limitation was that to
have an appropriate comparison with the 2006 study, scans
could not be separated into pediatric and adult scans; rather,
average values were calculated for the entire study sample. It
is our hope that our dissemination of these results will help to
increase the awareness of CT radiation dose and its risks as
well as prompt other groups to conduct similar surveys to
ensure patient safety in their own health regions.ConclusionIn Saskatchewan, significant provincial-wide dose reduc-
tions and decreases in variation were seen for CTs of the
chest and AP between 2006 and 2008. The fact that these
dose changes happened without any change in equipment
emphasizes the importance of scan protocols and techniques
in CT dose management. Unfortunately, this also was
accompanied by an increase in dose from head CT exami-
nations, which, combined with increased utilisation, resulted
in a 21% increase in radiation dose per capita from CT.
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